Skip to content
RVBA-TAKEDPrivate

Takeda

JP
Verified credentials
SBTi Validated1.5°C
Decarbonisation trajectory · all scopes
Scope 3· base 2022 · 2.8M tCO2e

Headline intensities

·Values in USD ($)· normalised from JPY at FY avg rate
Peer cohort: · lower is better
Revenue intensity
Carbon / $m revenue
tCO2e / $m revenue

Carbon per million dollars of revenue. The legacy industry-standard reference (CDP, MSCI). Useful for cross-sector context, but distorted by margin — high-margin firms appear artificially efficient. Read alongside the operational and asset intensities for the full picture.

Operational intensity
Carbon / $m OpEx
tCO2e / $m OpEx

OpEx (operating expenditure) is the running cost of the business — staff, services, energy, materials. This shows how carbon-intensive operations are per million dollars of spend. Removes the margin distortion that revenue-based ratios introduce.

Economic intensity
Carbon / $m EVIC
tCO2e / $m EVIC

EVIC (Enterprise Value Including Cash) is the firm's total capital footprint — equity + debt + cash + minority interest. The EU's standard intensity measure (SFDR PAI 3) — answers: how much carbon does each million of capital deployed in this business produce?

Asset intensity
Carbon / $m PP&E + leased
tCO2e / $m PP&E

PP&E (Property, Plant & Equipment) plus leased real-estate assets is the firm's physical infrastructure on the balance sheet. This shows the carbon intensity of that physical footprint — uses Scope 1+2+3 for consistency with the other headline intensities. Surfaces stranded-asset risk for asset-heavy firms.

Climate action evidence

388 records · 4 sources
Net-zero claim · FY2040 · 1.5°C · sbti
Takeda Pharmaceutical Company Limited commits to reach net-zero greenhouse gas emissions across the value chain by FY2040.
Carbon credits retired
25,685 tCO2e
4 retirements · FY2023 · third-party verified
No self-reported carbon removals for FY2023.
By credit quality
  • Avoidance / reductions11,685 tCO2e(45%)
  • Unclassified14,000 tCO2e(55%)
Retirements by year and credit class
2023
26ktCO₂e
2022
146ktCO₂e
2021
1.5MtCO₂e
Nature-based removalsAvoidanceUnclassified
Renewable electricity
100 %
Self-reported renewable electricity share, FY2023
Sources
  • · CarbonPlan OffsetsDB
  • · berkeley_voluntary_registry
  • · car
  • · gold_standard
Registry retirements are direct evidence; commitments are forward-looking pledges. EPA snapshot covers FY2019–FY2020.

Strategy & approach

How the firm describes its decarbonisation approach in its own words — alongside the headline numbers above. Self-reported, page-cited.

Approach to renewable energy
Renewable electricity across operations via on-site, PPAs, VPPAs

Takeda aims to achieve 100% renewable electricity across operations, prioritizing on-site renewables and power purchase agreements/voluntary power purchase agreements over unbundled energy attribute certificates (EACs). Virtual Power Purchase agreements have been secured in the U.S. and India. On-site photovoltaic panels at the Singapore manufacturing support building generate energy-positive output. Vienna site has operated on 100% renewable energy since 2007.

Self-reported · FY2023 · p.20
Approach to carbon removals
Nature-based carbon removals for residual <10% emissions

In line with SBTi Corporate Net-Zero Standard guidelines, Takeda will continue to invest in nature-based carbon removal projects, prioritizing solutions that benefit human health. Removals will address residual emissions (<10%) with high-quality, permanent carbon removals after >90% absolute reductions.

Self-reported · FY2023 · p.20
Primary decarbonisation levers
  • Sales fleet electrification

    40% of global fleet is electric vehicle (EV) or hybrid. Target to eliminate 100% of internal combustion engine vehicles.

  • Sustainable packaging & circular materials

    53% of secondary paper packaging (by weight) is from recycled content or sustainable forest certified, up from 42%. Moving from special colors (Pantone) to CMYK ink in printing for secondary packaging. Plans include PVC-free blister packs, pharma-grade bioplastics, and maximizing recycled content in secondary packaging (paper, plastic trays). New ENTYVIO SC multi-pack packaging estimated to reduce carton use by ~70% and leaflets by ~50% annually.

  • Manufacturing site decarbonization & heat pumps

    48 site-specific net-zero roadmaps covering manufacturing sites, BioLife and offices. Approved industry-first higher-temperature heat pump for steam generation (AHEAD project) in collaboration with AIT and Sustainable Process Heat GmbH — first time natural gas-free steam-generating heat pumps using 100% natural refrigerants will be integrated into industrial operation. Recognized with Net-Zero Industries Award National Winner Austria at COP28.

Dependent decarbonisation levers
  • Supplier engagement toward science-based targets

    56% of suppliers (by emissions) have set or committed to set science-based targets, up from 45% in FY2022. Target of 67% by FY2024 and pursuing 60% reduction in suppliers' operational emissions. Goal: 25% reduction in Scope 3 by FY2030 vs FY2022 baseline.

  • Hard-to-abate value chain investments (single-use plastics, medical waste)

    Focusing on collaborations to tackle hard-to-abate value chain emissions, including single-use plastics in plasma donation and disposal of regulated medical waste. Plans to enhance circularity in manufacturing (widespread solvent recycling).

  • Distribution & logistics — sea over air freight

    50% of shipped volume (by weight) transported by sea instead of air freight, reducing logistics-related emissions. Digital ePI program (PharmaLedger) for QDENGA reduces packaging materials and lowers shipping volume/weight.

Targets

Near-term

3 targets
ScopeBaseTargetReductionAlignmentProgressStatus
Scope 1 + 2Absolute20162030−65%1.5°Cinsufficient data
Scope 3Absolute20222030−25%
0.0% reductionof −25% target · 0% there
Off track
Scope 32035In corporate strategyabsolute-value target

Long-term

2 targets
ScopeBaseTargetReductionAlignmentProgressStatus
Scope 1 + 2Absolute20162035−90%1.5°Cinsufficient data
Scope 3Absolute20222040−90%
0.0% reductionof −90% target · 0% there
Off track

Net zero

2 targets
ScopeBaseTargetReductionAlignmentProgressStatus
Scope 1 + 2 + 3201620401.5°Cabsolute-value target
Scope 1 + 2 + 32040In corporate strategyabsolute-value target

⚠ Some targets show progress vs the earliest extracted year as a baseline approximation. The real base-year value will be used once historical reports are extracted.

Progress · absolute tCO2e

no Scope 1 + 2 trajectory data
Scope 3 trajectory vs target
Scope 3 · 25% by 2030
ActualLinear1.5°C
Partial profile

We haven't fully researched Takeda yet.

Request a full evidence-chained profile — we'll dig into their carbon, nature, social & water disclosure, find their facilities and sources, and email you when it's ready.

We’ll only use your email to notify you about this request.

Latest news· last 5 of 15

full news log →
  • Joined TNFD early adopter cohort

    In January 2024, Takeda joined the first cohort of adopters of the Taskforce for Nature-related Financial Disclosures recommendations and committed to identify, assess and disclose nature-related dependencies, impacts, risks and opportunities by fiscal year 2026.

    2023
  • Net-zero targets: Scope 1&2 by FY2035, value chain by FY2040

    Targets to reduce Scope 1&2 by 40% by FY2025, 65% by FY2030 and reach net-zero by FY2035 (vs FY2016 baseline). Scope 3: 25% reduction by FY2030, net-zero by FY2040 (vs FY2022 baseline). Aligned with SBTi Corporate Net-Zero Standard.

    2023
  • Singapore Green Mark Platinum Positive Energy certification

    Takeda's new manufacturing support building in Singapore earned a Green Mark Platinum Positive Energy certification — first for the biopharmaceutical industry in Singapore. Photovoltaic panels produce more energy than the building uses.

    2023
  • Sustainability by Design program with 10 LCAs completed

    Sustainability by Design Program established with 10 life-cycle assessments (LCAs) completed for high-impact products. From 2023, applying SbD framework to all new pipeline products.

    2023
  • Nature-based carbon removals for residual <10% emissions

    In line with SBTi Corporate Net-Zero Standard guidelines, Takeda will continue to invest in nature-based carbon removal projects, prioritizing solutions that benefit human health. Removals will address residual emissions (<10%) with high-quality, permanent carbon removals after >90% absolute reductions.

    2023

Latest reporting year· 4 earlier years on Data-by-year tab

all years + ratios →

2026

reporting year
Financials
Revenue
OpEx
FTE
Market cap (FY-end)
Climate
Scope 1
Scope 2 (market)
Scope 2 (location)
Scope 3 total

Source documents· FY2024

all documents →
sustainability report2024
via manual upload · 7.5 MB
extractedOPEN PDF ↗